Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117330963 | 11733096 | 3 | F | 20160810 | 20151113 | 20160811 | EXP | CA-ROCHE-1649243 | ROCHE | 55.00 | YR | M | Y | 0.00000 | 20160811 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117330963 | 11733096 | 1 | PS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | 103964 | |||||||||||
| 117330963 | 11733096 | 2 | SS | COPEGUS | RIBAVIRIN | 1 | Unknown | 21511 | |||||||||||
| 117330963 | 11733096 | 3 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | 0 | 400 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117330963 | 11733096 | 1 | Chronic hepatitis C |
| 117330963 | 11733096 | 2 | Chronic hepatitis C |
| 117330963 | 11733096 | 3 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117330963 | 11733096 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117330963 | 11733096 | Drug ineffective | |
| 117330963 | 11733096 | Hepatitis C | |
| 117330963 | 11733096 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |